Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1998 Jul;94(3):388–394. doi: 10.1046/j.1365-2567.1998.00521.x

Synergistic augmentative effect of interleukin-10 and CD27/CD70 interactions on B-cell immunoglobulin synthesis.

H Nagumo 1, K Agematsu 1
PMCID: PMC1364258  PMID: 9767422

Abstract

Interleukin-10 (IL-10) is a potent cytokine that regulates immunoglobulin synthesis by B cells. CD27/CD70 interactions by direct cell-to-cell contact are also needed to produce substantial amounts of immunoglobulin. We have investigated the effects of IL-10 and CD27/CD70 interactions on the immunoglobulin synthesis. In the presence of IL-10 stimulation, the production of IgG, IgM and IgA was increased synergistically by the addition of CD27 ligand (CD70)-transfectants in a dose-dependent manner, which was completely blocked by anti-CD70 monoclonal antibody. In contrast, CD70-transfectants additively enhanced the immunoglobulin production in the presence of IL-2, IL-4, or IL-6. The synergistic enhancement of the immunoglobulin production by IL-10 and CD70-transfectants was remarkable in highly purified CD27+ B cells, but there was no immunoglobulin production in CD27- B cells. Furthermore, by the addition of CD70-transfectants, the synthesis of IgG1, IgG2, IgG3 and IgG4 was also enhanced in the presence of IL-10. On the other hand, IL-10 diminished CD27 expression in B cells. B-cell proliferation was augmented by CD70-transfectants with IL-10 or IL-10 plus IL-2. The addition of IL-2 further augmented the immunoglobulin production which was synergistically enhanced by IL-10 and CD27 triggering. Taken together, the co-operative response to IL-10 and CD27/CD70 interactions regulates B-cell immunoglobulin production.

Full text

PDF
388

Images in this article

390Figure 1
on p.390
392Figure 3
on p.392

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agematsu K., Kobata T., Sugita K., Hirose T., Schlossman S. F., Morimoto C. Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70. J Immunol. 1995 Apr 15;154(8):3627–3635. [PubMed] [Google Scholar]
  2. Agematsu K., Kobata T., Yang F. C., Nakazawa T., Fukushima K., Kitahara M., Mori T., Sugita K., Morimoto C., Komiyama A. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur J Immunol. 1995 Oct;25(10):2825–2829. doi: 10.1002/eji.1830251017. [DOI] [PubMed] [Google Scholar]
  3. Agematsu K., Nagumo H., Oguchi Y., Nakazawa T., Fukushima K., Yasui K., Ito S., Kobata T., Morimoto C., Komiyama A. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood. 1998 Jan 1;91(1):173–180. [PubMed] [Google Scholar]
  4. Banchereau J., de Paoli P., Vallé A., Garcia E., Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science. 1991 Jan 4;251(4989):70–72. doi: 10.1126/science.1702555. [DOI] [PubMed] [Google Scholar]
  5. Bowman M. R., Crimmins M. A., Yetz-Aldape J., Kriz R., Kelleher K., Herrmann S. The cloning of CD70 and its identification as the ligand for CD27. J Immunol. 1994 Feb 15;152(4):1756–1761. [PubMed] [Google Scholar]
  6. Brière F., Bridon J. M., Chevet D., Souillet G., Bienvenu F., Guret C., Martinez-Valdez H., Banchereau J. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest. 1994 Jul;94(1):97–104. doi: 10.1172/JCI117354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bönig H., Körholz D., Pafferath B., Mauz-Körholz C., Burdach S. Interleukin 10 induced c-fos expression in human B cells by activation of divergent protein kinases. Immunol Invest. 1996 Jan-Mar;25(1-2):115–128. doi: 10.3109/08820139609059296. [DOI] [PubMed] [Google Scholar]
  8. Camerini D., Walz G., Loenen W. A., Borst J., Seed B. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J Immunol. 1991 Nov 1;147(9):3165–3169. [PubMed] [Google Scholar]
  9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  10. Clark E. A., Ledbetter J. A. How B and T cells talk to each other. Nature. 1994 Feb 3;367(6462):425–428. doi: 10.1038/367425a0. [DOI] [PubMed] [Google Scholar]
  11. Ding L., Linsley P. S., Huang L. Y., Germain R. N., Shevach E. M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol. 1993 Aug 1;151(3):1224–1234. [PubMed] [Google Scholar]
  12. Fiorentino D. F., Bond M. W., Mosmann T. R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989 Dec 1;170(6):2081–2095. doi: 10.1084/jem.170.6.2081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fluckiger A. C., Garrone P., Durand I., Galizzi J. P., Banchereau J. Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med. 1993 Nov 1;178(5):1473–1481. doi: 10.1084/jem.178.5.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goodwin R. G., Alderson M. R., Smith C. A., Armitage R. J., VandenBos T., Jerzy R., Tough T. W., Schoenborn M. A., Davis-Smith T., Hennen K. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell. 1993 May 7;73(3):447–456. doi: 10.1016/0092-8674(93)90133-b. [DOI] [PubMed] [Google Scholar]
  15. Hintzen R. Q., Lens S. M., Beckmann M. P., Goodwin R. G., Lynch D., van Lier R. A. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J Immunol. 1994 Feb 15;152(4):1762–1773. [PubMed] [Google Scholar]
  16. Jacquot S., Kobata T., Iwata S., Morimoto C., Schlossman S. F. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J Immunol. 1997 Sep 15;159(6):2652–2657. [PubMed] [Google Scholar]
  17. Maurer D., Fischer G. F., Fae I., Majdic O., Stuhlmeier K., Von Jeney N., Holter W., Knapp W. IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset. J Immunol. 1992 Jun 15;148(12):3700–3705. [PubMed] [Google Scholar]
  18. Maurer D., Holter W., Majdic O., Fischer G. F., Knapp W. CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol. 1990 Dec;20(12):2679–2684. doi: 10.1002/eji.1830201223. [DOI] [PubMed] [Google Scholar]
  19. Moore K. W., Vieira P., Fiorentino D. F., Trounstine M. L., Khan T. A., Mosmann T. R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science. 1990 Jun 8;248(4960):1230–1234. doi: 10.1126/science.2161559. [DOI] [PubMed] [Google Scholar]
  20. Morimoto C., Letvin N. L., Distaso J. A., Aldrich W. R., Schlossman S. F. The isolation and characterization of the human suppressor inducer T cell subset. J Immunol. 1985 Mar;134(3):1508–1515. [PubMed] [Google Scholar]
  21. Nonoyama S., Farrington M. L., Ochs H. D. Effect of IL-2 on immunoglobulin production by anti-CD40-activated human B cells: synergistic effect with IL-10 and antagonistic effect with IL-4. Clin Immunol Immunopathol. 1994 Sep;72(3):373–379. doi: 10.1006/clin.1994.1155. [DOI] [PubMed] [Google Scholar]
  22. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1890–1893. doi: 10.1073/pnas.89.5.1890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Servet-Delprat C., Bridon J. M., Blanchard D., Banchereau J., Brière F. CD40-activated human naive surface IgD+ B cells produce IgG2 in response to activated T-cell supernatant. Immunology. 1995 Jul;85(3):435–441. [PMC free article] [PubMed] [Google Scholar]
  24. Streuli M., Morimoto C., Schrieber M., Schlossman S. F., Saito H. Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens. J Immunol. 1988 Dec 1;141(11):3910–3914. [PubMed] [Google Scholar]
  25. Sugita K., Hirose T., Rothstein D. M., Donahue C., Schlossman S. F., Morimoto C. CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions. J Immunol. 1992 Nov 15;149(10):3208–3216. [PubMed] [Google Scholar]
  26. Sugita K., Torimoto Y., Nojima Y., Daley J. F., Schlossman S. F., Morimoto C. The 1A4 molecule (CD27) is involved in T cell activation. J Immunol. 1991 Sep 1;147(5):1477–1483. [PubMed] [Google Scholar]
  27. Takebe Y., Seiki M., Fujisawa J., Hoy P., Yokota K., Arai K., Yoshida M., Arai N. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol. 1988 Jan;8(1):466–472. doi: 10.1128/mcb.8.1.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M. G., te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., de Vries J. E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 1991 Oct 1;174(4):915–924. doi: 10.1084/jem.174.4.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van Lier R. A., Borst J., Vroom T. M., Klein H., Van Mourik P., Zeijlemaker W. P., Melief C. J. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol. 1987 Sep 1;139(5):1589–1596. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES